Shanghai Fosun Pharmaceutical (02196) repurchased 1.845 million shares on November 19 for approximately HK$27.769 million.
Shanghai Fosun Pharmaceutical (02196) announced that on November 19, 2026, the company repurchased 1.845 million shares for approximately HK$27.769 million, at a repurchase price of HK$14.9 to HK$15.1 per share.
Shanghai Fosun Pharmaceutical (02196) announced that on November 19, 2026, the company repurchased 1.845 million shares for approximately HK$27.769 million, at a repurchase price of HK$14.9 to HK$15.1 per share.
Related Articles

SHANGHAI PECHEM (00338) repurchased 1.454 million shares for HK$1.719 million on November 19.

CSPC PHARMA (01093) subsidiary receives US$15 million development milestone payment under the exclusive license agreement with CORBUS PHARMACEUTICALS for CRB-701 (SYS 6002)

Goldman Sachs Group, Inc.: Home Depot, Inc. and Lowe's Companies, Inc. See "Small Tickets Take the Lead" to Withstand the Chill in Demand; Strongly Recommends Four Building Materials Leaders Including Fortune Brands (FBIN.US)
SHANGHAI PECHEM (00338) repurchased 1.454 million shares for HK$1.719 million on November 19.

CSPC PHARMA (01093) subsidiary receives US$15 million development milestone payment under the exclusive license agreement with CORBUS PHARMACEUTICALS for CRB-701 (SYS 6002)

Goldman Sachs Group, Inc.: Home Depot, Inc. and Lowe's Companies, Inc. See "Small Tickets Take the Lead" to Withstand the Chill in Demand; Strongly Recommends Four Building Materials Leaders Including Fortune Brands (FBIN.US)






